Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism

被引:46
作者
Cui, Zhong-Hui [1 ]
Shen, Shi-Qiang [1 ]
Chen, Zu-Bing [1 ]
Hu, Chao [1 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Gen Surg, Wuhan 430060, Hubei Province, Peoples R China
关键词
Tumor vascular endothelial cells of hepatocellular carcinoma; Hepatic sinusoidal endothelial cells; MiRNA microarray; Mir-204-3p; Fibronectin; 1; PROGENITOR CELLS; DIFFERENTIATION; IDENTIFICATION; ANGIOGENESIS; RESISTANCE; ADHESION; MARKER;
D O I
10.3748/wjg.v20.i18.5493
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To investigate the mechanism by which miR-204-3p inhibits the growth of hepatocellular carcinoma (HCC) tumor endothelial cells (TECs). METHODS: Flow cytometry was used to identify HCCTECs and analyze their purity. Differentially expressed miRNAs in HCC TECs as compared to normal hepatic sinusoidal endothelial cells (HSECs) were examined using the HmiOA v4 Human miRNA OneArray((R)) microarray. miR-204-3p showed the most significant decrease in expression and was further studied. Over-expression of miR-204-3p was achieved using lentiviral transduction into TECs of HCC. The biological changes in HCC TECs before and after transduction were detected using MTT and apoptosis assays. The association between miR-204-3p and fibronectin 1 (FN1) was determined using the dual luciferase activity assay. Changes in FN1 protein expression before and after transduction were detected using Western blot analysis. RESULTS: Microarray results showed that compared to normal HSECs, 15 miRNAs were differentially expressed in HCC TECs, including 6 miRNAs with increased expression and 9 miRNAs with decreased expression. Among them, miR-204-3p showed the most significant decrease in expression (log2 = -1.233477, p = 0.000307). Over-expression of miR-204-3p in HCC TECs via lentiviral transduction significantly inhibited the proliferation of HCC TECs and promoted apoptosis. Results from the dual luciferase activity experiment showed that the luciferase intensity in the wild type FN1 group was significantly inhibited (p < 0.05), while that in the mutant FN1 group was not obviously affected. This observation indicated that FN1 was one of the potential targets of miR-204-3p. After over-expression of miR-204-3p in HCC TECs, Western blot analysis showed that the expression of FN1 protein was significantly inhibited. CONCLUSION: miR-204-3p acts on its potential target gene, FN1, and inhibits its expression, thus blocking the adhesion function of FN1 in promoting the growth of TECs. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:5493 / 5504
页数:12
相关论文
共 30 条
[1]   Epigenetic Silencing of miR-137 Is an Early Event in Colorectal Carcinogenesis [J].
Balaguer, Francesc ;
Link, Alexander ;
Lozano, Juan Jose ;
Cuatrecasas, Miriam ;
Nagasaka, Takeshi ;
Boland, C. Richard ;
Goel, Ajay .
CANCER RESEARCH, 2010, 70 (16) :6609-6618
[2]   Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes [J].
Biankin, Andrew V. ;
Waddell, Nicola ;
Kassahn, Karin S. ;
Gingras, Marie-Claude ;
Muthuswamy, Lakshmi B. ;
Johns, Amber L. ;
Miller, David K. ;
Wilson, Peter J. ;
Patch, Ann-Marie ;
Wu, Jianmin ;
Chang, David K. ;
Cowley, Mark J. ;
Gardiner, Brooke B. ;
Song, Sarah ;
Harliwong, Ivon ;
Idrisoglu, Senel ;
Nourse, Craig ;
Nourbakhsh, Ehsan ;
Manning, Suzanne ;
Wani, Shivangi ;
Gongora, Milena ;
Pajic, Marina ;
Scarlett, Christopher J. ;
Gill, Anthony J. ;
Pinho, Andreia V. ;
Rooman, Ilse ;
Anderson, Matthew ;
Holmes, Oliver ;
Leonard, Conrad ;
Taylor, Darrin ;
Wood, Scott ;
Xu, Qinying ;
Nones, Katia ;
Fink, J. Lynn ;
Christ, Angelika ;
Bruxner, Tim ;
Cloonan, Nicole ;
Kolle, Gabriel ;
Newell, Felicity ;
Pinese, Mark ;
Mead, R. Scott ;
Humphris, Jeremy L. ;
Kaplan, Warren ;
Jones, Marc D. ;
Colvin, Emily K. ;
Nagrial, Adnan M. ;
Humphrey, Emily S. ;
Chou, Angela ;
Chin, Venessa T. ;
Chantrill, Lorraine A. .
NATURE, 2012, 491 (7424) :399-405
[3]   Implanted adipose progenitor cells as physicochemical regulators of breast cancer [J].
Chandler, Emily M. ;
Seo, Bo Ri ;
Califano, Joseph P. ;
Eguiluz, Roberto C. Andresen ;
Lee, Jason S. ;
Yoon, Christine J. ;
Tims, David T. ;
Wang, James X. ;
Cheng, Le ;
Mohanan, Sunish ;
Buckley, Mark R. ;
Cohen, Itai ;
Nikitin, Alexander Yu ;
Williams, Rebecca M. ;
Gourdon, Delphine ;
Reinhart-King, Cynthia A. ;
Fischbach, Claudia .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (25) :9786-9791
[4]   Endoglin (CD105): A marker of tumor vasculature and potential target for therapy [J].
Dallas, Nikolaos A. ;
Samuel, Shaija ;
Xia, Ling ;
Fan, Fan ;
Gray, Michael J. ;
Lim, Sherry J. ;
Ellis, Lee M. .
CLINICAL CANCER RESEARCH, 2008, 14 (07) :1931-1937
[5]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[6]   Hallmarks of Cancer: The Next Generation [J].
Hanahan, Douglas ;
Weinberg, Robert A. .
CELL, 2011, 144 (05) :646-674
[7]   Regulation Mechanisms and Signaling Pathways of Autophagy [J].
He, Congcong ;
Klionsky, Daniel J. .
ANNUAL REVIEW OF GENETICS, 2009, 43 :67-93
[8]   Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma [J].
Heng, Daniel Y. C. ;
Bukowski, Ronald M. .
CURRENT CANCER DRUG TARGETS, 2008, 8 (08) :676-682
[9]   Gene regulation by transcription factors and microRNAs [J].
Hobert, Oliver .
SCIENCE, 2008, 319 (5871) :1785-1786
[10]   Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability [J].
Jones, Christopher A. ;
London, Nyall R. ;
Chen, Haoyu ;
Park, Kye Won ;
Sauvaget, Dominique ;
Stockton, Rebecca A. ;
Wythe, Joshua D. ;
Suh, Wonhee ;
Larrieu-Lahargue, Frederic ;
Mukouyama, Yoh-Suke ;
Lindblom, Per ;
Seth, Pankaj ;
Frias, Antonio ;
Nishiya, Naoyuki ;
Ginsberg, Mark H. ;
Gerhardt, Holger ;
Zhang, Kang ;
Li, Dean Y. .
NATURE MEDICINE, 2008, 14 (04) :448-453